Gelfond Richard L
GELFOND RICHARD L, CEO, reported a transaction classified as unknown at IMAX CORP involving 151253.000000 shares for an estimated $4824970.70. Reported holdings after the transaction were 916255.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 18, 2026
- Filing date
- Aug 20, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
IMAX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- unknown Code C
- Identifier
- 0001214659-26-010664 common shares
- Transaction date
- Aug 18, 2026 Filed Aug 20, 2026, 09:37 PM · 2d delay
- Shares
- 151,253 sh $31.90 per share
- Estimated value
- $4.82M Computed from shares × price
- Holdings after
- 916,255 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
- F2
Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
- F3
These options were issued in 2017 and are set to expire on January 3, 2027.
- F4
The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each…
- F5
This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactio…
0 other transactions
0 recent txs